Vivally System
Commercial- Indications
- Overactive bladder, Urge urinary incontinence, Urinary urgency
Company intelligence / Profile preview
The Vivally System is FDA-cleared for at-home treatment of overactive bladder symptoms. In multi-center clinical studies, 84% of patients were responders with significant improvements in OAB symptoms and quality of life. Reductions in voids, incontinence, and urgency episodes were sustained out to 12 months. High patient satisfaction rates and no significant device-related adverse events were reported
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avation Medical.